Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.

Main|Search|PHGKB


Last Posted: Feb 25, 2018

---

• Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.  
  Mocellin Simone, et al. BMC medicine 2018 2 (1) 20
• Men seeking counselling in a Breast Cancer Risk Evaluation Clinic.  
  Freitas Ana Catarina, et al. Ecancermedicalscience 2018 0 804
• https://gumc.georgetown.edu/news/Family-History-Increases-Breast-Cancer-Risk-Even-in-Older-Women  
  Georgetown Medical Center, Feb, 2018
• A study of association of Oncotype DX recurrence score with DCE-MRI characteristics using multivariate machine learning models.  
  Saha Ashirbani et al. Journal of cancer research and clinical oncology 2018 Feb
• Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.  
  West Allison H et al. Familial cancer 2018 Feb
• Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells.  
  Huang Yao et al. BMC cancer 2017 Mar 17(1) 199

more